NCT01162005 Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children Status COMPLETED Phase PHASE4
NCT01160276 Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients Status COMPLETED Phase PHASE1
NCT01154387 Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection Status UNKNOWN Phase PHASE1/PHASE2
NCT01135329 Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers Status TERMINATED Phase PHASE2
NCT01120028 Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy Status COMPLETED Phase PHASE2/PHASE3
NCT01118013 Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant Status TERMINATED Phase PHASE2
NCT01116232 Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation Status TERMINATED Phase PHASE2
NCT01084980 Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome Status COMPLETED Phase PHASE2/PHASE3
NCT01068067 Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients Status UNKNOWN Phase NA
NCT01068054 Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC) Status COMPLETED Phase PHASE2/PHASE3
NCT01056614 Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies Status COMPLETED Phase PHASE2
NCT01055964 a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients Status COMPLETED Phase PHASE3
NCT01049633 B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure Status NO_LONGER_AVAILABLE Phase N/A
NCT01047072 Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis Status WITHDRAWN Phase PHASE2
NCT01044745 Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer Status TERMINATED Phase PHASE2
NCT01038167 A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults Status COMPLETED Phase PHASE1
NCT01028716 Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT01027000 Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2